Attempting to defeat a heroin or painkiller addiction can be quite an undertaking to tackle alone. By electing to receive care at the Lebanon Comprehensive Treatment Center, you or your loved one can begin a recovery journey that is not only ample with support from qualified professionals, but transformative and truly life-changing. Our staff of experienced and devoted professionals are dedicated to helping men and women acquire the skills needed to recover and break free from the grips of opioid addictions.

Subscribe Here To Have Your Clinic Featured in this space

Following payment completion, please email us the clinic information that will be displayed here.

Lebanon, Pennsylvania is served by the Lebanon Comprehensive Treatment Center who offer both methadone and suboxone to individuals struggling with opiate addiction. Both methadone and suboxone have a well-known track record of success in fostering long-term addiction recovery. Below are links to more info on methadone program effectiveness, opioid dependency, addiction & recovery counseling, and job openings in methadone clinics.

Several organizations in Ohio recently hosted a town hall discussion on the opioid crisis still occurring there and across the country. News commentator, Eric Bolling, was a moderator of the event which was held at Cedarville University.

Eric and his wife, Adrienne, lost their 19 year old son in 2017 due to an accidental overdose with the powerful opioid, fentanyl.

This town hall discussion was designed to continue raising public awareness on the danger of opioid misuse and the continuing need for treatment and recovery support services to help families deal with this perpetual problem.

The Centers for Disease Control (CDC) report that there were 70,237 drug overdoses in 2017 with 47,600 involving opioids specifically. The article linked above states that the state of Ohio ranked 2nd in overdose deaths only behind West Virginia.

There is promising news in that more Americans are now being educated on opioid risks, and consequently are taking better precautions as well as actively accessing methadone & suboxone programs offering helpful medication-assistance and behavioral counseling. Saving lives and offering recovery are messages that are being heard.

In past decades, opioid addiction was skewed more heavily toward an older generation of adults. But today we have larger numbers of youth using opioids and experiencing addiction-related problems at earlier ages. Importantly, research has demonstrated conclusively that those who remain engaged in treatment for six months or more are much more likely to stabilize and to enjoy sustained success with recovery.

A recent Reuters Health article highlights the fact that many opioid-addicted youth are either not yet engaging in treatment or are exiting treatment too early. While more youth are being saved through the overdose reversal drug naloxone, a majority of addicted youth are still not receiving medicated-assisted treatments such as buprenorphine or methadone.

More work is necessary to open up treatment avenues for young adults across America, and to both educate & compel youth to seek MAT (medication-assisted treatment) as soon as possible.

The opioid addiction problem in America will not soon disappear. Drugs continue to find their way across the U.S. border through multiple avenues. Positive efforts are indeed bringing needed change, but the complexity and extent of opioid addiction in the U.S. will require a long-term, sustained commitment throughout the country. We must get the message out – especially to young people who may not fully grasp the power of addiction!

Opioid Use Disorder is the newer clinical terminology (from the DSM5) used to describe the full range of opioid problems ranging from mild opioid-related use issues to severe opioid addiction.

The CDC reports that in 2017 there were 72,287 deaths from overdose in the United States. That is certainly an alarming statistic. Of that number, 49,060 of those deaths were from opioids specifically – just in 2017. By contrast, there were 58,200 U.S. fatalities that resulted from the entire Vietnam war.

The good news is that government funding for opioid treatment is finally entering the stream on a local level. Increasing numbers of methadone clinics and physicians authorized to prescribe buprenorphine are moving into America’s more rural areas, ones that have historically been severely underserved.

As treatment for Opioid Use Disorder becomes more readily available, people struggling under the constant pressure of addiction will have an opportunity to apply the brake, and to veer onto a new path of stability and recovery. That being said, it is estimated that presently only 1 person of 10 with an opioid use disorder has sought treatment. For many opioid addicted people, treatment made the difference between life and death.

Choose a new path is more than words for those that have truly done so. Addiction is a highly persistent disease, but change is possible. Commitment and action are the necessary ingredients in opening the door to a new life. Opioid Use Disorder, in particular, is successfully treated with medication assistance. Science, research, and life experience have fortunately reinforced this fact with perfect clarity. Please find a local treatment provider today!

A Presidential briefing on March 19, 2018 in Manchester, NH was used to announce that ADAPT Pharma has volunteered to provide, for free, the life-saving medication NARCAN® to all U.S. high schools, colleges and universities.

NARCAN® is a name brand overdose antidote (based on naloxone) that restores breathing and consciousness in opioid overdose victims typically within five minutes.

ADAPT Pharma offers a 40% discount off wholesale pricing on the Narcan nasal spray to Law Enforcement agencies and Firefighters as well as non-profit community based organizations.

Seamus Mulligan, CEO of ADAPT, commented in a company press release that ADAPT is committed to raising awareness of opioid overdose risks and distributing NARCAN® widely so that it will be available to bystanders and emergency personnel who can offer immediate help in the event of a crisis.

Naltrexone is an opioid treatment medication that works very differently than either methadone or buprenorphine.

Naltrexone functions as an opioid blocker that interferes with the euphoric effects of opiates. Unlike methadone, naltrexone does not eliminate opioid withdrawal. So it is typically only begun following a successful period of opioid detoxification.

Naltrexone is taken as a pill or as a time-released injectable. It blocks the feeling of getting high thus deterring a person from continuing in active drug use with opioids. If there’s no pay off for using, why do it?

Some individuals who don’t necessarily require methadone or buprenorphine can effectively utilize naltrexone as a component of their recovery program. Vivitrol is the time-released, branded version of naltrexone that is taken once monthly as an injection. With Vivitrol, the naltrexone remains active in the bloodstream for 30 days and blocks the effects of heroin or other opiate use. This reinforces one’s focus on recovery choices and can reduce opioid cravings.

Patients receiving naltrexone may develop a lowered tolerance to opioids over time, and should remain aware of the risk of opioid overdose should they relapse. The medication is also used in the treatment of alcohol dependency and has been shown to reduce the euphoric effects of alcohol consumption.

Naltrexone is not to be confused with Naloxone. Naloxone is the opioid overdose reversal medication that has recently been in the news for saving thousands of lives across the country.

Methadone.US is an information center on methadone treatment, methadone clinics, and general opioid replacement therapies. This site profiles solutions for those suffering with opiate abuse or dependency, and aims to educate the public on the value of medication-assisted treatment. Buprenorphine.US is a companion site that features thousands of local physicians approved to write prescriptions for buprenorphine and popular drugs containing buprenorphine such as Suboxone.

The contents of Methadone.US are for general informational purposes only and are not intended to substitute for professional or medical evaluation, diagnosis, treatment, or advice. Users of this site are encouraged to contact your professional healthcare provider for medical assistance regarding addictive disorders, general health problems, mental health problems, and any & all health-related questions. Any information you find here or on other websites linked to from Methadone.US should be verified with your professional healthcare provider. Users who are experiencing a medical emergency should call your doctor or 911 immediately. Methadone.US is not affiliated with the pharmaceutical company Reckitt-Benckiser (the manufacturer of Suboxone).

Methadone.US does not guarantee the accuracy of information contained on this site or on sites linked to from this site. Reliance on any information appearing here is solely at your own risk. The users of this site shall indemnify and hold Methadone.US, its parent company, employees, agents, and sponsors harmless from and against any and all damages, liabilities, losses, costs, and expenses, including reasonable attorney’s fees, arising out of or related to use of information, services, or products mentioned at this website. Methadone.US makes no guarantee, whatsoever, regarding clinics or advertisers listed on this site, and bears no responsibility whatsoever for information, claims, or results associated with methadone clinics, advertisers, or other service providers listed on this site. All users are encouraged to perform their own independent examination & review of any website or service listed on Methadone.US.